Akebia Therapeutics | AKBA - Current Liabilities


Akebia Therapeutics reported $162.94M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
Acadia Pharmaceuticals USD 277.11M 79.47M Dec/2025
Agios Pharmaceuticals USD 82.21M 7.45M Dec/2025
Akebia Therapeutics USD 162.94M 29.56M Dec/2025
Alnylam Pharmaceuticals USD 1.47B 89.13M Dec/2025
Amgen USD 25.49B 3.7B Dec/2025
Ardelyx USD 88.6M 5.22M Dec/2025
Astellas Pharma JPY 1.32T 873M Dec/2025
AstraZeneca USD 30.62B 3.44B Dec/2025
Bayer EUR 32.58B 3.63B Dec/2025
BioMarin Pharmaceutical USD 759.03M 39.41M Dec/2025
Celltrion KRW 4.01T 343.96B Sep/2025
Cspc Pharmaceutical CNY 10.18B 65.36M Dec/2025
Deva Holding AS TRY 6.43B 1.18B Sep/2023
Dianthus Therapeutics USD 30.73M 6.88M Dec/2025
Exelixis USD 405.64M 31.86M Dec/2025
Fresenius Medical Care EUR 6.25B 485.68M Dec/2025
GlaxoSmithKline GBP 21.39B 57M Dec/2025
Ionis Pharmaceuticals USD 783M 120.46M Dec/2025
Ironwood Pharmaceuticals USD 242.5M 9.98M Sep/2025
J&J USD 54.13B 3.26B Dec/2025
Kangmei Pharma CNY 5.81B 57.93M Sep/2025
Karyopharm Therapeutics USD 92.06M 4.9M Dec/2025
Knight Therapeutics CAD 165.26M 12.58M Dec/2025
Laboratorios Farma EUR 199.84M 121.75M Dec/2023
Lexicon Pharmaceuticals USD 20.87M 853K Dec/2025
Malin Corporation EUR 1000K 500K Dec/2024
Medical Developments International AUD 5.56M 2.26M Dec/2025
Moderna USD 1.99B 306M Dec/2025
Nektar Therapeutics USD 53.54M 12.8M Dec/2025
Neuren Pharmaceuticals AUD 4.34M 3.58M Dec/2025
Organigram Holdings CAD 94.05M 32.11M Dec/2025
Ovoca Bio EUR 186K 2.26M Jun/2025
Pharma Mar EUR 93.88M 4.94M Dec/2025
Prothena USD 40.84M 10.59M Dec/2025
PTC Therapeutics USD 968.43M 102.18M Dec/2025
Qiagen NV USD 512.14M 461.26M Dec/2025
Regeneron Pharmaceuticals USD 4.37B 56.7M Dec/2025
Roche Holding CHF 28B 421M Dec/2025
Sanofi EUR 28.35B 3.76B Dec/2025
Sarepta Therapeutics USD 1.1B 173.86M Dec/2025
Sartorius EUR 1.81B 254.3M Sep/2025
Sino Biopharmaceutical CNY 24.85B 5.29B Jun/2025
Tectonic Therapeutic USD 9.67M 293K Dec/2025
Tilray USD 259.32M 8.32M Sep/2025
Vanda Pharmaceuticals USD 145.16M 27.29M Dec/2025
Zealand Pharma A/S 664.96M 513.61M Dec/2025
Zz Pientze Pharmaceu CNY 2.14B 1.06B Sep/2025